COMPOSITION  
                                  Each enteric coated tablet contains:
                                  L-Ornithine L-Aspartate   150 mg
                                  Pancreatin I.P.   100 mg
 

L-Ornithine : L-Ornithine present in BIOHEP acts on urea cycle. L-Ornithine acts as an activator of ornithine-carbamyl transferase and carbamyl phosphate synthetase. L-Ornithine acts as a substrate for urea genesis. Thus eliminates ammonia from blood.

L-Aspartate : L-Aspartate present in BIOHEP acts on Tricarboxylic Citric Acid cycle. L-Aspartate serves as a stimulus for hepatic glutamine synthesis in the perivenous scavenge cells, which may be defective in acute and chronic liver disease. The inactive cells are activated and the new cells are generated. Thus, the energy utilization in damaged liver is improved.

 L-Ornithine & L-Aspartate are absorbed into the capillaries of the villi, present in small intestine.
They are distributed via portal circulation to the liver and then distributed throughout the body.Metabolism takes place in the liver. The nitrogenous part, the amino group (NH2) is converted to ammonia (NH3) and then combined with CO2 forming urea.They are excreted in urine and faeces.

 

INDICATIONS

  • Hepatitis
  • Fatty Liver
  • Liver Cirrhosis
  • Hepatic Encephalopathy
  • Jaundice
 

DOSAGE
1 - 2 tablets 3 times a day for 3 months.

 

 

 
 Learn More . . .
 Composition
 Indications
 Dosage
 
| Home | Products | Marketing | Distribution | Link | Contacts | Sitemap |
DISCLAIMER |© KEE Pharma Ltd. 2004                                                                                                                Powered By : A.G. WEBSOLUTIONS